The Regents of the University of California is the governing board of the University of California. In 2019, the Regents of University of California and Evolve Biosystems, a company founded in 2012 by faculty of the University of California, jointly filed a patent infringement suit against Abbott Laboratories. Additionally, NeuroSigma, a Los Angeles-based bioelectronics company that is commercializing trigeminal nerve stimulation (TNS), is the exclusive licensee of the Regent's rights in all TNS-related patents owned by the Regents or co-owned by the Regents and NeuroSigma.
| Loading Documents... |
